BMI1 and biliary tract neoplasm: To verify these statements, we used PTC-209 (BMI1 Polycomb Ring Finger Oncogene (BMI1) inhibitor) that we recently demonstrated to inhibit clonogenic growth in biliary tract cancer cells [6].